These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12477823)

  • 1. Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251.
    Van Rompay KK; Greenier JL; Cole KS; Earl P; Moss B; Steckbeck JD; Pahar B; Rourke T; Montelaro RC; Canfield DR; Tarara RP; Miller C; McChesney MB; Marthas ML
    J Virol; 2003 Jan; 77(1):179-90. PubMed ID: 12477823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals.
    Greenier JL; Van Rompay KK; Montefiori D; Earl P; Moss B; Marthas ML
    Virol J; 2005 Feb; 2():11. PubMed ID: 15710048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.
    Van Rompay KK; Abel K; Earl P; Kozlowski PA; Easlick J; Moore J; Buonocore-Buzzelli L; Schmidt KA; Wilson RL; Simon I; Moss B; Rose N; Rose J; Marthas ML
    Vaccine; 2010 Feb; 28(6):1481-92. PubMed ID: 19995539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques.
    Jensen K; Nabi R; Van Rompay KKA; Robichaux S; Lifson JD; Piatak M; Jacobs WR; Fennelly G; Canfield D; Mollan KR; Hudgens MG; Larsen MH; Amedee AM; Kozlowski PA; De Paris K
    J Virol; 2016 Aug; 90(16):7285-7302. PubMed ID: 27252535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.
    Van Rompay KK; Abel K; Lawson JR; Singh RP; Schmidt KA; Evans T; Earl P; Harvey D; Franchini G; Tartaglia J; Montefiori D; Hattangadi S; Moss B; Marthas ML
    J Acquir Immune Defic Syndr; 2005 Feb; 38(2):124-34. PubMed ID: 15671796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
    Ourmanov I; Brown CR; Moss B; Carroll M; Wyatt L; Pletneva L; Goldstein S; Venzon D; Hirsch VM
    J Virol; 2000 Mar; 74(6):2740-51. PubMed ID: 10684290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques.
    Curtis AD; Walter KA; Nabi R; Jensen K; Dwivedi A; Pollara J; Ferrari G; Van Rompay KKA; Amara RR; Kozlowski PA; De Paris K
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):310-325. PubMed ID: 30303405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.
    Seth A; Ourmanov I; Schmitz JE; Kuroda MJ; Lifton MA; Nickerson CE; Wyatt L; Carroll M; Moss B; Venzon D; Letvin NL; Hirsch VM
    J Virol; 2000 Mar; 74(6):2502-9. PubMed ID: 10684264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
    Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ
    AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques.
    Marthas ML; Van Rompay KK; Abbott Z; Earl P; Buonocore-Buzzelli L; Moss B; Rose NF; Rose JK; Kozlowski PA; Abel K
    Vaccine; 2011 Apr; 29(17):3124-37. PubMed ID: 21377510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
    Connor RI; Montefiori DC; Binley JM; Moore JP; Bonhoeffer S; Gettie A; Fenamore EA; Sheridan KE; Ho DD; Dailey PJ; Marx PA
    J Virol; 1998 Sep; 72(9):7501-9. PubMed ID: 9696847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251.
    Otsyula MG; Miller CJ; Tarantal AF; Marthas ML; Greene TP; Collins JR; van Rompay KK; McChesney MB
    Virology; 1996 Aug; 222(1):275-8. PubMed ID: 8806509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy.
    Uberla K; Rosenwirth B; Ten Haaft P; Heeney J; Sutter G; Erfle V
    J Med Primatol; 2007 Feb; 36(1):2-9. PubMed ID: 17359459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques.
    Nilsson C; Sutter G; Walther-Jallow L; Ten Haaft P; Åkerblom L; Heeney J; Erfle V; Böttiger P; Biberfeld G; Thorstensson R
    J Gen Virol; 2002 Apr; 83(Pt 4):807-818. PubMed ID: 11907330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.
    Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Pavone-Cossut MR; Macchia I; Farcomeni S; Tenner-Racz K; Racz P; Ensoli B; Titti F
    J Med Primatol; 2007 Aug; 36(4-5):180-94. PubMed ID: 17669207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.
    Sparger EE; Dubie RA; Shacklett BL; Cole KS; Chang WL; Luciw PA
    Virology; 2008 May; 374(2):261-72. PubMed ID: 18261756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
    Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI
    J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.